Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People’s Democratic Republic using multi-valent seroprevalence data
Open Access
- 29 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-8
Abstract
Measles and rubella are important causes of morbidity and mortality globally. Despite high coverage reported for measles vaccination, outbreaks continue to occur in some countries. The reasons for these outbreaks are poorly understood. We apply Bayesian methods to multi-valent seroprevalence data for measles and rubella, collected 2 years and 3 months after a mass measles-rubella vaccination campaign in Lao PDR to estimate the immunogenicity and vaccination coverage. When the vaccination coverage was constrained to exceed 95% or 90%, consistent with officially-reported values, the immunogenicity of the measles vaccine component was unexpectedly low (75% (95% CR: 63–82%) and 79% (CR: 70–87%) respectively. The estimated immunogenicity increased after relaxing constraints on the vaccination coverage, with best-fitting values of 83% (95% CR: 73–91%) and 97% (95% CR: 90–100%) for the measles and rubella components respectively, with an estimated coverage of 83% (95% CR: 80–88%). The findings suggest that, if the vaccine coverage was as high as that reported, continuing measles outbreaks in Lao PDR, and potentially elsewhere, may be attributable to suboptimal immunogenicity attained in mass campaigns. Vaccine management in countries with high reported levels of coverage and ongoing measles outbreaks needs to be reviewed if measles elimination targets are to be achieved.Keywords
Funding Information
- National Center for Global Health and Medicine
This publication has 19 references indexed in Scilit:
- Estimating Vaccine Coverage from Serial Trivariate Serologic Data in the Presence of Waning ImmunityEpidemiology, 2015
- Estimating vaccination coverage for the trivalent measles–mumps–rubella vaccine from trivariate serological dataStatistics in Medicine, 2012
- Assessing evidence for behaviour change affecting the course of HIV epidemics: A new mathematical modelling approach and application to data from ZimbabweEpidemics, 2009
- Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007Sexually Transmitted Infections, 2008
- Bayesian melding for estimating uncertainty in national HIV prevalence estimatesSexually Transmitted Infections, 2008
- Evaluation of Eight Anti-Rubella Virus Immunoglobulin G Immunoassays That Report Results in International Units per MilliliterJournal of Clinical Microbiology, 2008
- Probabilistic projections of HIV prevalence using Bayesian meldingThe Annals of Applied Statistics, 2007
- Modelling age‐dependent force of infection from prevalence data using fractional polynomialsStatistics in Medicine, 2005
- Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillanceVaccine, 2002
- Estimating vaccine coverage by using computer algebraMathematical Medicine and Biology: A Journal of the IMA, 2000